H-DL-Lys-DL-Asn-Gly-DL-Tyr-Gly-Gly-DL-Ser-Gly-DL-Asn-DL-Arg-DL-Trp-DL-Val-DL-His-DL-Cys-Gly-DL-Ala-Gly-DL-xiIle-DL-Val-Gly-al
| Internal ID | 9eba341e-2834-487b-a03a-27f3b789e569 |
| Taxonomy | Organic Polymers > Polypeptides |
| IUPAC Name | 2-[[2-[[2-[[2-[[2-[[2-[[2-[[4-amino-2-(2,6-diaminohexanoylamino)-4-oxobutanoyl]amino]acetyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]acetyl]amino]-N-[5-carbamimidamido-1-[[1-[[1-[[3-(1H-imidazol-5-yl)-1-[[1-[[2-[[1-[[2-[[3-methyl-1-[[3-methyl-1-oxo-1-(2-oxoethylamino)butan-2-yl]amino]-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxopentan-2-yl]butanediamide |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C85H129N29O24S/c1-8-44(6)71(84(138)114-69(42(2)3)82(136)93-24-25-115)112-68(125)38-97-72(126)45(7)103-64(121)35-101-77(131)60(40-139)111-79(133)56(28-48-32-92-41-102-48)110-83(137)70(43(4)5)113-81(135)55(27-47-31-95-52-16-10-9-14-50(47)52)109-78(132)53(17-13-23-94-85(90)91)107-80(134)58(30-62(89)119)105-67(124)37-100-76(130)59(39-116)106-65(122)34-96-63(120)33-98-74(128)54(26-46-18-20-49(117)21-19-46)104-66(123)36-99-75(129)57(29-61(88)118)108-73(127)51(87)15-11-12-22-86/h9-10,14,16,18-21,25,31-32,41-45,51,53-60,69-71,95,116-117,139H,8,11-13,15,17,22-24,26-30,33-40,86-87H2,1-7H3,(H2,88,118)(H2,89,119)(H,92,102)(H,93,136)(H,96,120)(H,97,126)(H,98,128)(H,99,129)(H,100,130)(H,101,131)(H,103,121)(H,104,123)(H,105,124)(H,106,122)(H,107,134)(H,108,127)(H,109,132)(H,110,137)(H,111,133)(H,112,125)(H,113,135)(H,114,138)(H4,90,91,94) |
| InChI Key | PMLDSUSBRKQBNO-UHFFFAOYSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C85H129N29O24S |
| Molecular Weight | 1973.20 g/mol |
| Exact Mass | 1971.9485973 g/mol |
| Topological Polar Surface Area (TPSA) | 856.00 Ų |
| XlogP | -7.70 |
| Atomic LogP (AlogP) | -11.78 |
| H-Bond Acceptor | 29 |
| H-Bond Donor | 31 |
| Rotatable Bonds | 63 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.9736 | 97.36% |
| Caco-2 | - | 0.8634 | 86.34% |
| Blood Brain Barrier | - | 0.6250 | 62.50% |
| Human oral bioavailability | - | 0.5857 | 58.57% |
| Subcellular localzation | Mitochondria | 0.5681 | 56.81% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.7992 | 79.92% |
| OATP1B3 inhibitior | + | 0.9377 | 93.77% |
| MATE1 inhibitior | - | 0.6809 | 68.09% |
| OCT2 inhibitior | + | 0.5250 | 52.50% |
| BSEP inhibitior | + | 0.9754 | 97.54% |
| P-glycoprotein inhibitior | + | 0.7418 | 74.18% |
| P-glycoprotein substrate | + | 0.8719 | 87.19% |
| CYP3A4 substrate | + | 0.7482 | 74.82% |
| CYP2C9 substrate | - | 0.6016 | 60.16% |
| CYP2D6 substrate | - | 0.8165 | 81.65% |
| CYP3A4 inhibition | - | 0.5511 | 55.11% |
| CYP2C9 inhibition | - | 0.7874 | 78.74% |
| CYP2C19 inhibition | - | 0.7610 | 76.10% |
| CYP2D6 inhibition | - | 0.8561 | 85.61% |
| CYP1A2 inhibition | - | 0.8468 | 84.68% |
| CYP2C8 inhibition | + | 0.8552 | 85.52% |
| CYP inhibitory promiscuity | - | 0.9071 | 90.71% |
| UGT catelyzed | + | 0.7000 | 70.00% |
| Carcinogenicity (binary) | - | 0.8800 | 88.00% |
| Carcinogenicity (trinary) | Non-required | 0.5838 | 58.38% |
| Eye corrosion | - | 0.9842 | 98.42% |
| Eye irritation | - | 0.8953 | 89.53% |
| Skin irritation | - | 0.7796 | 77.96% |
| Skin corrosion | - | 0.9247 | 92.47% |
| Ames mutagenesis | - | 0.5900 | 59.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7130 | 71.30% |
| Micronuclear | + | 0.6900 | 69.00% |
| Hepatotoxicity | - | 0.5875 | 58.75% |
| skin sensitisation | - | 0.8487 | 84.87% |
| Respiratory toxicity | + | 0.7889 | 78.89% |
| Reproductive toxicity | + | 0.9444 | 94.44% |
| Mitochondrial toxicity | + | 0.8000 | 80.00% |
| Nephrotoxicity | - | 0.8313 | 83.13% |
| Acute Oral Toxicity (c) | III | 0.5967 | 59.67% |
| Estrogen receptor binding | - | 0.5878 | 58.78% |
| Androgen receptor binding | + | 0.7331 | 73.31% |
| Thyroid receptor binding | + | 0.8077 | 80.77% |
| Glucocorticoid receptor binding | + | 0.8448 | 84.48% |
| Aromatase binding | + | 0.8248 | 82.48% |
| PPAR gamma | + | 0.7661 | 76.61% |
| Honey bee toxicity | - | 0.6370 | 63.70% |
| Biodegradation | - | 0.8500 | 85.00% |
| Crustacea aquatic toxicity | - | 0.6000 | 60.00% |
| Fish aquatic toxicity | + | 0.7983 | 79.83% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.92% | 98.95% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 99.87% | 97.23% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 99.71% | 90.20% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 99.50% | 91.11% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 98.40% | 91.81% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 98.40% | 100.00% |
| CHEMBL3038469 | P24941 | CDK2/Cyclin A | 98.12% | 91.38% |
| CHEMBL2535 | P11166 | Glucose transporter | 98.03% | 98.75% |
| CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 97.60% | 85.00% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 97.49% | 96.09% |
| CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 97.44% | 96.28% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 97.27% | 98.94% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 97.04% | 99.17% |
| CHEMBL4296013 | Q5VWK5 | Interleukin-23 receptor | 97.02% | 88.00% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 96.92% | 96.67% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 96.74% | 100.00% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 96.67% | 88.56% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 96.67% | 98.33% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 96.19% | 88.42% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 96.13% | 97.21% |
| CHEMBL3837 | P07711 | Cathepsin L | 96.06% | 96.61% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 95.98% | 94.45% |
| CHEMBL236 | P41143 | Delta opioid receptor | 95.92% | 99.35% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 95.71% | 98.89% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 94.94% | 95.56% |
| CHEMBL3091268 | Q92753 | Nuclear receptor ROR-beta | 94.62% | 95.50% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 94.50% | 95.00% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 94.11% | 90.08% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 93.78% | 89.63% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 93.43% | 93.10% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 93.39% | 96.90% |
| CHEMBL4801 | P29466 | Caspase-1 | 93.24% | 96.85% |
| CHEMBL1937 | Q92769 | Histone deacetylase 2 | 93.22% | 94.75% |
| CHEMBL1293287 | P14735 | Insulin-degrading enzyme | 93.07% | 88.10% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 92.13% | 95.17% |
| CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 91.84% | 82.86% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 91.44% | 98.05% |
| CHEMBL2288 | Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 91.03% | 91.71% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 90.18% | 97.64% |
| CHEMBL5939 | Q9NZ08 | Endoplasmic reticulum aminopeptidase 1 | 90.05% | 100.00% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 89.02% | 95.38% |
| CHEMBL5261 | Q7L7X3 | Serine/threonine-protein kinase TAO1 | 88.85% | 89.33% |
| CHEMBL4530 | P00488 | Coagulation factor XIII | 86.93% | 96.00% |
| CHEMBL227 | P30556 | Type-1 angiotensin II receptor | 86.24% | 99.53% |
| CHEMBL4581 | P52732 | Kinesin-like protein 1 | 85.95% | 93.18% |
| CHEMBL4145 | Q9UKV0 | Histone deacetylase 9 | 85.82% | 85.49% |
| CHEMBL3401 | O75469 | Pregnane X receptor | 85.77% | 94.73% |
| CHEMBL1744525 | P43490 | Nicotinamide phosphoribosyltransferase | 85.64% | 96.25% |
| CHEMBL2664 | P23526 | Adenosylhomocysteinase | 85.37% | 86.67% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 84.60% | 89.50% |
| CHEMBL249 | P25103 | Neurokinin 1 receptor | 84.59% | 99.17% |
| CHEMBL4793 | Q86TI2 | Dipeptidyl peptidase IX | 84.45% | 96.95% |
| CHEMBL2072 | P35499 | Sodium channel protein type IV alpha subunit | 84.36% | 92.32% |
| CHEMBL1287628 | Q9Y5S8 | NADPH oxidase 1 | 83.73% | 95.48% |
| CHEMBL2035 | P08912 | Muscarinic acetylcholine receptor M5 | 82.95% | 94.62% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 82.70% | 96.00% |
| CHEMBL213 | P08588 | Beta-1 adrenergic receptor | 82.47% | 95.56% |
| CHEMBL2431 | P31751 | Serine/threonine-protein kinase AKT2 | 81.67% | 98.33% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 81.11% | 95.89% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 80.88% | 82.38% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 80.22% | 91.19% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 163049588 |
| LOTUS | LTS0225521 |
| wikiData | Q104195031 |